We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Working on ‘Special-Use Pathway,’ Accelerated Approval Guidance
FDA Working on ‘Special-Use Pathway,’ Accelerated Approval Guidance
March 28, 2012
The clinical trials process took center stage recently as Center for Drug Evaluation and Research Director Janet Woodcock proposed speeding drug approvals by allowing smaller trials and discussed upcoming guidance on accelerated approval endpoints.